These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28477167)

  • 21. Early detection of myocardial involvement by T
    Yu L; Sun J; Sun J; Li J; Dong Y; Zhou X; Greiser A; Han Y; Zhang Q; Xie Q; Chen Y
    J Magn Reson Imaging; 2018 Aug; 48(2):415-422. PubMed ID: 29328539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial Late Gadolinium Enhancement: Accuracy of T1 Mapping-based Synthetic Inversion-Recovery Imaging.
    Varga-Szemes A; van der Geest RJ; Spottiswoode BS; Suranyi P; Ruzsics B; De Cecco CN; Muscogiuri G; Cannaò PM; Fox MA; Wichmann JL; Vliegenthart R; Schoepf UJ
    Radiology; 2016 Feb; 278(2):374-82. PubMed ID: 26230908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.
    Małek ŁA; Werys K; Kłopotowski M; Śpiewak M; Miłosz-Wieczorek B; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Marczak M; Witkowski A
    Magn Reson Imaging; 2015 Jul; 33(6):718-24. PubMed ID: 25863138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques.
    Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Romeo F; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    Eur Radiol; 2017 Nov; 27(11):4639-4649. PubMed ID: 28500368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping.
    Xu K; Xu HY; Xu R; Xie LJ; Yang ZG; Yu L; Zhou B; Fu H; Liu H; Cai XT; Guo YK
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):110. PubMed ID: 34645467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis.
    Kranzusch R; Aus dem Siepen F; Wiesemann S; Zange L; Jeuthe S; Ferreira da Silva T; Kuehne T; Pieske B; Tillmanns C; Friedrich MG; Schulz-Menger J; Messroghli DR
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):6. PubMed ID: 31955712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of inversion time on the precision of myocardial late gadolinium enhancement quantification evaluated with synthetic inversion recovery MR imaging.
    Varga-Szemes A; van der Geest RJ; Schoepf UJ; Spottiswoode BS; De Cecco CN; Muscogiuri G; Wichmann JL; Mangold S; Fuller SR; Maurovich-Horvat P; Merkely B; Litwin SE; Vliegenthart R; Suranyi P
    Eur Radiol; 2017 Aug; 27(8):3235-3243. PubMed ID: 28050692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.
    Oda S; Utsunomiya D; Nakaura T; Yuki H; Kidoh M; Morita K; Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Ishida T; Tsujita K; Ueda M; Yamashita T; Ando Y; Hata H; Yamashita Y
    Circ J; 2017 Jun; 81(7):1014-1021. PubMed ID: 28367859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.
    Avitzur N; Satriano A; Afzal M; Narous M; Mikami Y; Hansen R; Dobko G; Flewitt J; Lydell CP; Howarth AG; Chow K; Fine NM; White JA
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1937-1946. PubMed ID: 30014362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis.
    Liu Y; Zhu J; Chen M; Wang L; Zhu M; Weng Z; Hu C
    Ann Transl Med; 2022 Jul; 10(14):794. PubMed ID: 35965812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2015 Oct; 132(16):1570-9. PubMed ID: 26362631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions.
    Kali A; Choi EY; Sharif B; Kim YJ; Bi X; Spottiswoode B; Cokic I; Yang HJ; Tighiouart M; Conte AH; Li D; Berman DS; Choi BW; Chang HJ; Dharmakumar R
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1019-1030. PubMed ID: 26298071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial function in cardiac amyloidosis.
    Di Bella G; Minutoli F; Madaffari A; Mazzeo A; Russo M; Donato R; Zito C; Aquaro GD; Piccione MC; Pedri S; Vita G; Pingitore A; Carerj S
    J Cardiovasc Med (Hagerstown); 2016 Feb; 17(2):113-21. PubMed ID: 25222078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance.
    Graham-Brown MP; Singh AS; Gulsin GS; Levelt E; Arnold JA; Stensel DJ; Burton JO; McCann GP
    BMC Cardiovasc Disord; 2018 Jul; 18(1):145. PubMed ID: 30005636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome.
    Diekmann J; Koenig T; Thackeray JT; Derlin T; Czerner C; Neuser J; Ross TL; Schäfer A; Tillmanns J; Bauersachs J; Bengel FM
    J Nucl Med; 2022 Sep; 63(9):1415-1423. PubMed ID: 35210301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.